Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma: a Turkish Gynecologic Oncology Study

Comert G. K., Turkmen O., Boyraz G., Yalcin I., Altin D., Karalok A., ...Daha Fazla

BALKAN MEDICAL JOURNAL, cilt.36, sa.4, ss.229-234, 2019 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 4
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4274/balkanmedj.galenos.2019.2018.12.75
  • Dergi Adı: BALKAN MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.229-234
  • Anahtar Kelimeler: Adjuvant, carcinosarcoma, chemotherapy, radiotherapy, uterine neoplasms, MIXED MULLERIAN TUMORS, PHASE-III TRIAL, RECURRENCE PATTERNS, UTERUS, IFOSFAMIDE, CISPLATIN, CHEMOTHERAPY, PACLITAXEL, LYMPHADENECTOMY, CARBOPLATIN
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: Uterine carcinosarcoma is rare neoplasm that mostly presents as metastatic disease. Stage is one of the most important prognostic factor, however, the management of the early stage uterine carcinosarcoma is still controversial.